Microperimetric changes after intravitreal bevacizumab injection for exudative age-related macular degeneration

Acta Ophthalmologica

Volumn 90, Issue 1, 2012, Pages 71-75

  Ozdemir, Hakan ^a   Karacorlu, Murat ^a   Senturk, Fevzi ^a   Karacorlu, Serra Arf ^a   Uysal, Omer ^b  

^a Istanbul Retina Institute Inc   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

exudative age related macular degeneration; intravitreal bevacizumab; microperimetry; retinal sensitivity

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; EXUDATIVE MACULAR DEGENERATION; EYE FIXATION; HUMAN; MALE; MICROPERIMETRY; OPTICAL COHERENCE TOMOGRAPHY; PERIMETER; PRIORITY JOURNAL; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; SCOTOMA; VISION TEST; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CONTRAST SENSITIVITY; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETINA; RETREATMENT; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 84856558580     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01838.x     Document Type: Article

References (21)

1. Algvere PV, Steen B, Seregard S, &, Kvanta A, (2008): A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different duration. Acta Ophthalmol 86: 482-489.
2. Bolz M, Simader C, Ritter M, Ahlers C, Benesch T, Pruente C, &, Schmidt-Erfurth UM, (2009): Morphological and functional analysis of the loading regimen with intravitreal ranibizumab in neovascular AMD. Br J Ophthalmol. doi:.
3. Ergun E, Maar N, Radner W, Barbazetto I, Schmidt-Erfurth U, &, Stur M, (2003): Scotoma size and reading speed in patients with subfoveal occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 110: 65-69. (Pubitemid 36068728)
4. Eyetech Study Group (2003): Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. Ophthalmology 110: 979-986.
5. Ferrara N, Hillan KJ, Gerber HP, &, Novotny W, (2004): Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 3: 391-400. (Pubitemid 38618122)
6. Ferris FL III, Fine SL, &, Hyman L, (1984): Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 102: 1640-1642. (Pubitemid 15204559)
7. Furino C, Boscia F, Recchimurzo N, Besozzi G, Cardascia N, Sborgia L, Niro A, &, Sborgia C, (2009): Intravitreal bevacizumab for treatment naive subfoveal occult choroidal neovascularization in age related macular degeneration. Acta Ophthalmol 87: 404-407.
8. McClure ME, Hart PM, Jackson AJ, Stevenson MR, &, Chakravarthy U, (2000): Macular degeneration: do conventional measurements of impaired visual function equate with visual disability? Br J Opthalmol 84: 244-250. (Pubitemid 30251677)
9. Michels S, Rosenfeld PJ, Puliafito CA, Marcus EN, &, Venkatraman AS, (2005): Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twelve-week results of an uncontrolled open-label clinical study. Ophthalmology 112: 1035-1047. (Pubitemid 40797459)
10. Midena E, Radin PP, Pilotto E, Ghirlando A, Convento E, &, Varano M, (2004): Fixation pattern and macular sensitivity in eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. A microperimetry study. Semin Ophthalmol 19: 55-61. (Pubitemid 39658410)
11. Moshfeghi AA, Rosenfeld PJ, Puliafito CA, Michels S, Marcus EN, Lenchus JD, &, Venkatraman AS, (2006): Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study. Ophthalmology 113: 2002. el-2002.e12. Epub 2006 Oct 5.
12. Ng EW, &, Adamis AP, (2005): Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol 40: 352-368. (Pubitemid 40942262)
13. Parravano M, Oddone F, Tedeschi M, Schiano LD, Chiaravalloti A, Ripandelli G, &, Varano M, (2009): Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration patients treated with ranibizumab. Retina 29: 329-334.
14. Pedersen KB, Sjolie AK, &, Moller F, (2008): Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration in treatment naïve patients. Acta Ophthalmol 87: 714-719.
15. Prager F, Michels S, Simader C, Geitzenauer W, &, Schmidt Erfurth U, (2008): Changes in retinal sensitivity in patients with neovascular age-related macular degeneration after systemic bevacizumab (Avastin) therapy. Retina 28: 682-688. (Pubitemid 351655119)
16. Rosenfeld PJ, Moshfeghi AA, &, Puliafito CA, (2005): Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascularization in age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36: 331-335. (Pubitemid 41073112)
17. Schmidt-Erfurth UM, Elsner H, Terai N, Benecke A, Dahmen G, &, Michels SM, (2004): Effects of verteporfin therapy on central visual field function. Ophthalmology 111: 931-939. (Pubitemid 38586687)
18. Schneider U, Inheffen W, Gelisken F, &, Kreissig I, (1996): Assessment of visual function in choroidal neovascularization with scanning laser microperimetry and simultaneous indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol 234: 612-617. (Pubitemid 26340603)
19. Springer C, Bultmann S, Volcker HE, &, Rohrschneider K, (2005): Fundus perimetry with the Micro Perimeter 1 in normal individuals: comparison with conventional threshold perimetry. Ophthalmology 112: 848-854. (Pubitemid 40631504)
20. Tezel TH, Del Priore LV, Flowers BE, Grosof DH, Benenson IL, Zamora RL, &, Kaplan HJ, (1996): Correlation between scanning laser ophthalmoscope microperimetry and anatomic abnormalities in patients with subfoveal neovascularization. Ophthalmology 103: 1829-1836. (Pubitemid 26403736)
21. Varano M, &, Scassa C, (1998): Scanning laser ophthalmoscope microperimetry. Semin Ophthalmol 13: 203-209. (Pubitemid 29042610)